Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
This keychain could stop an opioid overdose; carry the antidote — not the burden of guilt
ST. LOUIS — Easy access to life-saving naloxone (better known by the brand name Narcan) could’ve prevented the fatal overdose of Danielle Wilder’s close friend in college, the tragedy-prompted entrepreneur said. Her friend was in possession of naloxone — a fast-acting medicine that can reverse the deadly impacts of an opioid overdose when delivered near-immediately…
Brookside restaurant spot shifts from Irish to Mexican flavors as two families expand their dream
Two longtime friends and their daughters — all seasoned restaurant workers — are joining together in a new East Brookside restaurant they can call their own. Muy Caliente Grill & Cantina is scheduled to open later this month at 751 E. 63rd St., Suite 110, in the former Brady & Fox restaurant. Owners Fredy Rivera…
Landlord’s solution to Kansas housing crisis: 3D print his own home inventory
TOPEKA — Regularly confronted with a lack of supply in the housing market — and the subsequent higher prices — landlord and general capital investor Chris Stemler faced a multi-dimensional challenge. “I thought to myself, ‘How do I help solve an inventory problem?’ the Topeka-based Trident Homes founder said. “I know I’ve got renters who…
Just-launched retail hub gets first tenant, battling ‘blight of the heart’ on Troost corner
‘We are each other’s bootstraps’ Transforming a long-vacant building along Troost into a space for neighborhood small businesses is about empowering the entrepreneurs already living and working in the east side community, said Father Justin Mathews. The newly unveiled RS Impact Exchange — built within the renovated, 1920-built Baker Shoe Building at 3108-3116 Troost Ave.…